Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia
TCTR20221014007Phase 2Completed
- Sponsor
- Arifin Achmad Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of nifedipine, labetalol and hydralazine in preeclampsia (3 arms), sponsored by Arifin Achmad Hospital. Started Jun 2021; status: completed.
02
Drugs
nifedipinelabetalolhydralazine
03
Conditions
preeclampsia
Beyond the preview
Go deeper on TCTR20221014007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221014007.